Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Patent
1989-04-26
1994-04-26
Berch, Mark L.
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C07D48704
Patent
active
053068254
ABSTRACT:
Physostigmine derivatives with acetylcholinesterase inhibition properties, of general formula: ##STR1## in which R is a linear alkyl of from 2 to 20 C. atoms, a branched alkyl, a cycloalkyl or an aryl, when R' is H, or R and R' are linear alkyl of from 2 to 20 C. atoms.
REFERENCES:
patent: 2860166 (1958-11-01), Newcomer
patent: 2908530 (1959-10-01), Rudner
patent: 3972934 (1976-08-01), Marshall
patent: 4120691 (1978-10-01), Levitt
patent: 4127405 (1978-11-01), Levitt
patent: 4163112 (1979-07-01), Stach
patent: 4169719 (1979-10-01), Levitt
patent: 4190432 (1980-02-01), Levitt
patent: 4214890 (1980-07-01), Levitt
patent: 4231784 (1980-11-01), Levitt
patent: 4257802 (1981-03-01), Levitt
patent: 4278679 (1981-07-01), Madison et al.
patent: 4500342 (1985-02-01), Aya et al.
patent: 4586951 (1986-05-01), Aya et al.
patent: 4602941 (1986-07-01), Aya et al.
patent: 4765985 (1988-08-01), Leeson
patent: 4791107 (1988-12-01), Hamer
Barton "Comprehensive Organic Chemistry", vol. 2 p. 1086 (1982).
Yang, Chem. Abs 107, 242543z (1987).
First, Euro. J. Pharm. 83, (1982) 233-241.
Mar., Advanced Organic Chem., 2nd Edition, pp. 349-352 (1988).
The Merck Index, 9th Edition, p. 961 (1976).
Brufani Mario
Castelland Claudio
Marta Maurizio
Oliverio Alberto
Pavone Flaminia
Berch Mark L.
Consiglio Nazionale Delle Ricerche
LandOfFree
Physostigmine derivatives with acetylcholinesterase inhibition p does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Physostigmine derivatives with acetylcholinesterase inhibition p, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Physostigmine derivatives with acetylcholinesterase inhibition p will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1712718